CD39 抗体
Quick Overview for CD39 抗体 (ABIN610073)
抗原
See all CD39 (ENTPD1) 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
特异性
- CD39 Molecule of approximately 80 kd.
-
纯化方法
- Protein A purified
-
免疫原
-
Human WM-1 (Waldenstrom's macroglobulinemia) cell line.
Type of Immunogen: Cells -
亚型
- IgG1
-
-
-
-
应用备注
-
Approved: Flo, IP, WB
Usage: The applications listed have been tested for the unmodified form of this product. Other forms have not been tested. -
说明
-
Target Species of Antibody: Human
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- Lot specific
-
缓冲液
- 50 mM sodium phosphate, pH 7.5, 100 mM potassium chloride, 150 mM sodium chloride
-
储存液
- Azide free
-
注意事项
- Do not freeze. Open under aseptic conditions.
-
储存条件
- 4 °C
-
储存方法
- Store at 4°C. Do not freeze. Open under aseptic conditions.
-
-
-
Antimyeloma efficacy of thalidomide in the SCID-hu model." in: Blood, Vol. 100, Issue 12, pp. 4162-8, (2002) (PubMed).
: "Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors." in: Molecular biology of the cell, Vol. 12, Issue 2, pp. 449-62, (2001) (PubMed).
: "Differential regulation of fibroblast growth factor (FGF) receptor-1 mRNA and protein by two molecular forms of basic FGF. Modulation of FGFR-1 mRNA stability." in: The Journal of biological chemistry, Vol. 271, Issue 10, pp. 5663-70, (1996) (PubMed).
: "Antisense inhibition of basic fibroblast growth factor induces apoptosis in vascular smooth muscle cells." in: The Journal of biological chemistry, Vol. 271, Issue 21, pp. 12578-84, (1996) (PubMed).
: "
-
Antimyeloma efficacy of thalidomide in the SCID-hu model." in: Blood, Vol. 100, Issue 12, pp. 4162-8, (2002) (PubMed).
-
- CD39 (ENTPD1) (Ectonucleoside Triphosphate diphosphohydrolase 1 (ENTPD1))
-
别名
- CD39
-
背景
-
Name/Gene ID: ENTPD1
Synonyms: ENTPD1, ATPDase, CD39, CD39 antigen, Ecto-apyrase, Ecto-ATPDase 1, Ecto-ATP diphosphohydrolase 1, Ecto-ATPase 1, NTPDase-1, NTPDase 1 -
基因ID
- 953
-
UniProt
- P49961
抗原
-